Olivia Rudin

Olivia joined Granite Bio in July 2024 as Senior Research Associate to conduct and support pre-clinical and translational studies. She brings over 10 years' experience in cell-biology, immuno-oncology, cell metabolism and vaccine research.

Prior to joining Granite Bio, Olivia worked as Senior Research Associate at Cimeio Therapeutics on their Shielded-Cell and Immunotherapy Pairs platform, performing cell-based assays. There, she was able to build on the knowledge that she had developed during her previous role at Idorsia Pharmaceuticals, where she worked in drug discovery on different cellular targets.

Olivia started her career in the field of microbiology with Limmatech Biologics, identifying new generation antibacterial vaccines. She completed her Masters in Infection Biology & Epidemiology at the Swiss Tropical and Public Health Institute in Basel. In 2022 she also finished a Certificate of Advanced Studies in Personalized Molecular Oncology at the University of Basel.